GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hubei Xingfa Chemicals Group Co 600141.SS · CNY

Materials · Shanghai · 🇨🇳 China

Compare

23.29

-1.69%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥29.30bn

FY2016FY2025

Net income

CN¥1.49bn

FY2016FY2025

Free cash flow

−CN¥633.8m

FY2016FY2025

Shareholders' equity

CN¥22.01bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥29.30bnCN¥28.40bnCN¥28.28bnCN¥30.31bnCN¥23.90bnCN¥18.32bnCN¥18.04bnCN¥17.86bnCN¥15.76bnCN¥14.54bn
Gross profitCN¥8.05bnCN¥5.32bnCN¥4.38bnCN¥10.63bnCN¥7.98bnCN¥2.42bnCN¥2.41bnCN¥3.16bnCN¥2.62bnCN¥1.87bn
Research and developmentCN¥1.31bnCN¥1.18bnCN¥1.12bnCN¥1.23bnCN¥862.2mCN¥374.1mCN¥274.9mCN¥281.5mCN¥234.0mCN¥164.8m
Operating incomeCN¥2.71bnCN¥2.25bnCN¥1.78bnCN¥8.21bnCN¥5.93bnCN¥769.7mCN¥483.2mCN¥1.77bnCN¥839.4mCN¥272.6m
Net incomeCN¥1.49bnCN¥1.60bnCN¥1.40bnCN¥5.85bnCN¥4.28bnCN¥621.2mCN¥302.5mCN¥402.3mCN¥318.1mCN¥102.0m
Diluted earnings per share1.291.361.104.933.860.600.350.530.480.15

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥52.02bnCN¥47.78bnCN¥44.56bnCN¥41.61bnCN¥34.48bnCN¥30.42bnCN¥28.94bnCN¥25.66bnCN¥21.74bnCN¥21.38bn
Cash and short-term investments—CN¥1.53bnCN¥2.32bnCN¥4.79bnCN¥3.20bnCN¥2.18bnCN¥1.68bnCN¥1.85bnCN¥965.7mCN¥783.5m
Total liabilitiesCN¥27.63bnCN¥24.89bnCN¥22.59bnCN¥20.28bnCN¥18.89bnCN¥19.47bnCN¥19.22bnCN¥17.20bnCN¥14.63bnCN¥14.73bn
Debt—CN¥14.54bnCN¥12.95bnCN¥12.11bnCN¥13.25bnCN¥13.14bnCN¥14.07bnCN¥12.41bnCN¥11.15bnCN¥11.14bn
Shareholders' equityCN¥22.01bnCN¥21.46bnCN¥20.70bnCN¥20.30bnCN¥14.04bnCN¥9.59bnCN¥8.28bnCN¥7.54bnCN¥6.10bnCN¥5.88bn
Shares outstanding1,160m1,178m1,272m1,187m1,108m1,031m856m765m663m660m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.62bnCN¥1.59bnCN¥1.45bnCN¥6.88bnCN¥5.34bnCN¥2.41bnCN¥1.04bnCN¥1.90bnCN¥1.90bnCN¥1.15bn
Capital spending−CN¥2.25bn−CN¥1.50bn−CN¥2.43bn−CN¥2.36bn−CN¥1.39bn−CN¥1.04bn−CN¥1.12bn−CN¥953.7m−CN¥928.6m−CN¥956.3m
Free cash flow−CN¥633.8mCN¥85.2m−CN¥978.8mCN¥4.52bnCN¥3.95bnCN¥1.37bn−CN¥85.6mCN¥945.0mCN¥974.2mCN¥189.7m
Dividends paid−CN¥1.57bn−CN¥985.4m−CN¥1.46bn−CN¥555.9m−CN¥279.7m−CN¥103.1m−CN¥200.2m−CN¥756.1m−CN¥721.6m−CN¥670.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥10.00bnCN¥7.45bnCN¥5.52bnCN¥9.16bnCN¥7.39bnCN¥7.23bnCN¥6.35bnCN¥8.65bn
Gross profitCN¥1.85bnCN¥1.02bnCN¥1.27bnCN¥1.59bnCN¥1.40bnCN¥934.9mCN¥1.36bnCN¥1.68bn
Operating incomeCN¥1.14bnCN¥535.9mCN¥564.0mCN¥922.6mCN¥711.8mCN¥472.8mCN¥490.6mCN¥744.7m
Net incomeCN¥578.9mCN¥256.6mCN¥173.7mCN¥591.6mCN¥416.2mCN¥310.6mCN¥287.1mCN¥509.3m
Diluted earnings per share0.500.220.150.510.360.270.240.43
Cash from operations———CN¥522.0mCN¥475.0m−CN¥352.0m—CN¥336.0m
Capital spending−CN¥934.0m−CN¥616.0m−CN¥634.0m−CN¥575.0m−CN¥640.0m−CN¥398.0m−CN¥401.0m−CN¥137.0m
Free cash flow———−CN¥53.0m−CN¥165.0m−CN¥750.0m—CN¥199.0m
Total assetsCN¥56.28bnCN¥53.37bnCN¥52.02bnCN¥51.74bnCN¥50.18bnCN¥49.57bnCN¥47.78bnCN¥47.12bn
Cash and short-term investments———CN¥1.47bnCN¥1.94bnCN¥1.58bnCN¥1.53bnCN¥1.87bn
DebtCN¥10.85bnCN¥8.81bnCN¥10.26bnCN¥6.55bnCN¥13.31bnCN¥12.37bnCN¥11.17bnCN¥11.20bn
Shareholders' equityCN¥24.95bnCN¥25.01bnCN¥22.01bnCN¥21.88bnCN¥21.29bnCN¥21.95bnCN¥21.46bnCN¥21.23bn

Financial ratios

Data as of 19 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin27.5%18.8%15.5%35.1%33.4%13.2%
Operating margin9.2%7.9%6.3%27.1%24.8%4.2%
Net margin5.1%5.6%5.0%19.3%17.9%3.4%
Return on equity6.8%7.5%6.8%28.8%30.5%6.5%
Return on assets2.9%3.4%3.1%14.1%12.4%2.0%
Free cash flow yield11.5%9.0%10.5%26.8%20.9%11.5%
Revenue growth3.2%0.4%-6.7%26.8%30.5%1.5%
Earnings growth-6.8%14.3%-76.1%36.7%589.2%105.4%
Current ratio0.60x0.59x0.65x0.87x0.65x0.50x
Debt to equity0.47x0.52x0.59x0.51x0.79x1.16x
Equity ratio42.3%44.9%46.5%48.8%40.7%31.5%
Interest coverage323.93x5.10x4.47x18.48x10.14x1.31x
R&D as a share of sales4.5%4.2%3.9%4.1%3.6%2.0%
Buybacks as a share of market value1.5%7.4%-7.1%-7.1%-7.5%-20.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.1%9.8%9.0%
Operating income-30.9%28.6%33.3%
Net income-36.6%19.2%34.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin23.2%24.4%24.5%21.4%
Operating margin8.6%12.9%13.7%10.6%
Net margin5.4%8.9%9.6%6.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings26.916.016.65.99.818.329.119.629.482.0
Price to sales1.40.90.81.11.80.60.50.40.60.6

Dividends and splits

Per share, in the currency the company pays

Paid for 21 years. Last went ex-dividend on 22 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.501.000.601.000.500.250.100.20
  • 6-for-5 split · 14 Jun 2018
  • 1.15-for-1 split · 2 Jul 2010
  • 6-for-5 split · 5 May 2009
  • 6-for-5 split · 20 May 2008
  • 1-to-1 reverse split · 5 Apr 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.